Vanguard Personalized Indexing Management, LLC Adagio Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $4.59 Billion
- Q1 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 17,575 shares of ADGI stock, worth $58,173. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,575
Previous 17,575
-0.0%
Holding current value
$58,173
Previous $58,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ADGI
# of Institutions
94Shares Held
64MCall Options Held
828KPut Options Held
23.4K-
Lee Ainslie Maverick Capital LTD | Dallas, Tx11.8MShares$38.9 Million0.77% of portfolio
-
Deep Track Capital, LP Greenwich, CT11MShares$36.3 Million1.2% of portfolio
-
M28 Capital Management LP Stamford, CT9.25MShares$30.6 Million28.73% of portfolio
-
Alphabet Inc. Mountain View, CA4.53MShares$15 Million0.66% of portfolio
-
Slate Path Capital LP New York, NY3.74MShares$12.4 Million0.25% of portfolio
About Adagio Therapeutics, Inc.
- Ticker ADGI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 108,831,000
- Market Cap $505M
- Description
- Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...